US Stock MarketDetailed Quotes
FRPRF 4D PHARMA PLC
- 0.000000
- 0.0000000.00%
15min DelayTrading Apr 19 09:30 ET
0Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)180.34MShares0.21200052wk High0.00P/B0Float Cap0.21200052wk Low--Dividend TTM180.34MShs Float2.110000Historical High--Div YieldTTM0.00%Amplitude0.212000Historical Low--Avg Price1Lot Size
About 4D PHARMA PLC Company
4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Company Profile
SymbolFRPRF
Company Name4D PHARMA PLC
CEOMr. Duncan Joseph Peyton
MarketPink Market
Employees88
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Websitehttps://www.4dpharmaplc.com
Company Executives
- Name
- Position
- Salary
- Duncan Joseph Peyton
- Chief Executive Officer and Director
- 254.00K
- Dr. Alexander James Stevenson
- Chief Scientific Officer and Director
- 218.00K
- John Doyle
- Chief Financial Officer
- --
- Professor Axel Gaston Glasmacher
- Non-Executive Chairman of the Board
- 103.00K
- Dr. Katrin Juliane Rupalla, PhD
- Independent Director
- 69.00K
- Dr. Edgardo Baracchini,PhD
- Independent Director
- 69.00K
- Paul Victor Maier
- Independent Director
- 67.00K
- Dr. Alexander Donald Macrae
- Independent Director
- 74.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg